HAI-Floxuridine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HAI-Floxuridine, covering 2026-02-02 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT) [Phase 2]